Welcome to This Week in Pediatrics. This week we're covering 10 notable papers spanning the care of extremely preterm infants, a re-evaluation of common and future therapeutics, and new approaches to assessing and preventing chronic conditions. Let's dive in. [PAUSE] We begin in the NICU, with a focus on our most vulnerable patients: the extremely preterm infant. A series of papers this week pro…

This week's papers:

Novel activity and participation scales for children, adolescents, and young adults with postacute infection and vaccination syndromes and/or ME/CFS. — European journal of pediatrics 2026
Comparing neuroprotective drug efficacy in rodent neonatal brain injury models. — Pediatric research 2026
Atopic dermatitis. — Nature reviews. Disease primers 2026
Early Amino Acid Intake in ELBW Infants: School-Aged Outcomes From a Randomized Controlled Trial. — Pediatrics 2026
Respiratory trajectories of infants born before 26 weeks of gestation from birth to discharge: an exploratory analysis of a randomised controlled trial. — The Lancet. Child & adolescent health 2026
Plasma signals of lung tumor promotion for molecular cancer prevention. — Cell 2026
Randomised, Multicentre Clinical Trial Found That Hypertonic Saline Did Not Reduce the Length of Stay of Hospitalised Patients With Acute Bronchiolitis. — Acta paediatrica (Oslo, Norway : 1992) 2026
Clinical pharmacology insights from recent cell and gene therapy approvals relevant to pediatrics. — Pediatric research 2026
Caring for the smallest hearts: cardiovascular phenotypes and assessment in tiny babies. — Pediatric research 2026
Clinical study: Cardiovascular outcomes after a 14-week exercise intervention in young adults born preterm. — Pediatric research 2026